faculty portrait if available
Girish Shah
Professor
School Basic Pharm & Toxicol Sci
PHAR 300
318-342-1693
ULM logo

Girish V Shah, PhD
Professor, Pharmacy
Calhoun Endowed Chair

Recent Publications

El Sayed, K., Shah, G. (2011). Discovery, design, and development of anti-invasive natural product leads. Methods in Molecular Biology Protocols- Drug Design and Discovery (pp. 55-76).
Baraka, H., Khanfar, M., Williams, J., El Giar, E., Shah, G., El Sayed, K. Bioactive Natural, Biocatalytic, and Semisynthetic Tobacco Cembranoids. Planta Medica.
Mudit, M., Khanfar, M., Muralidharan, A., Thomas, S., Shah, G., El Sayed, K. (2009). Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products. (pp. 1531-1538). Washington DC, Elsevier: Bioorganic & Medicinal Chemistry.
Shah, G., Muralidharan, A., Thomas, S., Gokulgandhi, M., Mudit, M., Khanfar, M., El Sayed, K. (2009). Identification of a small molecule(s) class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis (pp. 509-522). Washington DC/American Association for Cancer Research: Molecular Cancer Therapeutics.
Shah, G., Muralidharan, A., Gokulgandhi, M., Thomas, S. (2009). Cadherin switching and activation of beta-catenin signaling underlie proinvasive actions of calcitonin-calcitonin receptor axis in prostate cancer (pp. 1018-30). American Society of Biochemistry and Molecular Biology: Journal of Biological Chemistry.
Shah, G. (2008). Calcitonin in Cancer. Heidelberg: Springer Press.
Shah, G., Thomas, S., Muralidharan, A., Liu, Y., Hermonat, P., Williams, J., Choudhary, J. (2008). Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion and inflammatory pathways (pp. 953-64). London: Endocrine-related Cancer.

Research Grants

El Sayed, K. (Principal), Shah, G. (Co-Principal), Khalil, A. (Co-Principal), "Louisiana Campuses Research Initiative (LACRI) 2012. El Sayed KA, PI, Lead optimization of novel antimetastatic agents with cell-cell adhesion and tight-junction promoting effects for the control of recurring prostate cancer." (Funded), Sponsored By ULM, The University of Louisiana at Monroe, $20000. (January 01 2013 - December 31 2013).

Awards & Honors

April 2007 Invited Speaker.

October 2006 Invited Speaker.

2003 Teaching Award in Oncology.

1999 Teaching Award in Oncology.

1999 President's Award for Research Excellence.

February 1994 Invited Speaker.

March 1984 'Zertifikat Deutsch als fremd Sprache.

September 1983 Alexander von Humboldt Award.

November 1980 World Health Organization Fellowship.

1980 Nils Lagerloff Award.

Courses Taught

PHAR 5027NEUROPHARMACOLOGY, 1 course(s)

PHAR 5058ADVANCED CANCER PHARMACOLOGY, 8 course(s)

PHRD 4027PRINCIPLES OF DRUG ACTION II, 7 course(s)

PHRD 4081INFECTIOUS DISEASES MODULE, 8 course(s)

PHRD 4083GASTRO NUTRITION & HEPTIC MOD, 7 course(s)

PHRD 4085THERAPEUTICS III, 3 course(s)

PHRD 5022THERAPEUTICS VI, 2 course(s)

PHRD 5031RESPIRATORY MODULE, 6 course(s)

PHRD 5035HEMATOLOGY/ONCOLOGY MODULE, 7 course(s)

PHRD 5047THERAPEUTICS VIII, 2 course(s)